These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis. Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines. Sarkar K; Das PK J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956 [TBL] [Abstract][Full Text] [Related]
7. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo. Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis. Kole L; Das L; Das PK J Infect Dis; 1999 Sep; 180(3):811-20. PubMed ID: 10438370 [TBL] [Abstract][Full Text] [Related]
9. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. Melby PC; Chandrasekar B; Zhao W; Coe JE J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239 [TBL] [Abstract][Full Text] [Related]
10. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease. Mukherjee S; Ukil A; Das PK Antimicrob Agents Chemother; 2007 May; 51(5):1700-7. PubMed ID: 17339373 [TBL] [Abstract][Full Text] [Related]
12. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways. Kar S; Ukil A; Das PK Eur J Immunol; 2009 Mar; 39(3):741-51. PubMed ID: 19197936 [TBL] [Abstract][Full Text] [Related]
13. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity. Choudhury R; Das P; De T; Chakraborti T Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312 [TBL] [Abstract][Full Text] [Related]
14. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275 [TBL] [Abstract][Full Text] [Related]
15. Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide. Singh PP; Singal P J Neuroimmune Pharmacol; 2007 Dec; 2(4):338-51. PubMed ID: 18040852 [TBL] [Abstract][Full Text] [Related]
17. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T; Anam K; Ali N Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644 [TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity. Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987 [TBL] [Abstract][Full Text] [Related]
19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
20. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]